In a recent study, the transfer of a therapeutic microRNA targeting mutant Huntingtin gene (HTT) within neuronal EVs caused efficient HTT decrease in vitro and in vivo in the brain of HD animal models [193]. This evidence concerns the gene HTT and Huntington disease.